Search for: "Novozymes A/S" Results 41 - 60 of 68
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
20 Jul 2011, 4:04 am by Marie Louise
Here is Think IP Strategy’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
15 Jul 2011, 5:26 am by Lorraine Fleck
Plaintiiff drops second ever Twitter squatting lawsuit due to possible sanctions for procedural errors http://ti.me/rbz1bo Lady Gaga’s YouTube Account Temporarily Suspended Over Alleged Copyright Violation http://bit.ly/nclU3B and http://cnet.co/naPQ5u IP news on Paul Allen, Novozymes, Samsung and Lady Gaga http://bloom.bg/qjhlaL Google Says Oracle Seeks ‘Harassing’ Deposition of Page in Patent Lawsuit http://bloom.bg/lLJCTR Cyberwar Plan Has New Focus on… [read post]
3 Jul 2011, 11:08 pm by Marie Louise
Here is Think IP Strategy’s weekly selection of top intellectual property news breaking in the blogosphere and internet. [read post]
29 Jun 2011, 3:34 am by Marie Louise
(Patent Docs) Fortical – US: Challenge to Unigene’s osteoporosis patent, among the reexamination requests for the week of June 20, 2011 (WHDA) Glucoamyl L 706+ / Glucoamyl LG20 – US: Novozymes files patent infringement suit against Central Trading Enterprises over Glucoamyl L 706+ and Glucoamyl LG20 products (Patent Docs) Glumetza (Metformin) – US: Patent infringement complaint in response to Para IV certification: Depomed, Inc. et al. v. [read post]
26 Jun 2011, 8:22 pm by Patent Docs
Novozymes A/S et al. v. [read post]
9 May 2011, 4:28 am by Marie Louise
Here is Think IP Strategy’s weekly selection of top intellectual property news breaking in the blogosphere and internet. [read post]
9 Mar 2011, 3:00 am by Marie Louise
Here is Think IP Strategy’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
23 Feb 2011, 3:35 am by Marie Louise
Here is Think IP Strategy’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
15 Feb 2011, 5:26 pm by Marie Louise
: Novozymes v Danisco (Holman’s Biotech IP Blog) US: Preliminary injunction softened after claims are rejected in reexamination: Celsis In Vitor v CellzDirect (Reexamination Alert) Products Alpharen – EU: General Court: Boards of appeal are judges not doctors! [read post]
4 Jan 2011, 4:08 pm
Because the jury's verdict on willfulness was not supported by substantial evidence, this court affirms the district court's grant of JMOL of no willfulness; the district court's alternative grant of a new trial for willfulness is thus rendered moot. [read post]
18 Oct 2010, 3:07 am by Marie Louise
No. 337-TA-740 in Certain Toner Cartridges and Components Thereof (ITC 337 Update) LG Electronics – ITC institutes investigation (337-TA-742) regarding Certain Digital Televisions (ITC Law Blog) (ITC 337 Update) Medtronics – Medtronic settles with Wall Cardiovascular in stent patent dispute (Patent Docs) Norgren – ITC decides to review initial determination in Certain Connecting Devices (337-TA-587) (ITC Law Blog) Novozymes – District Court denies Novozymes… [read post]
22 Sep 2010, 2:24 pm by Edna Vassilovski
The US and PCT patent organizations published the following patents and applications during the first weeks of September 2010: US Patent Pub. [read post]
14 Jul 2010, 6:47 pm by Kelly
Cefetra (Holman’s Biotech IP Blog) (Patent Baristas) (Patent Docs) (IP Watch) (EPLAW) Germany : German parliament members seek limited patent terms in EU-India FTA (IP Watch) Netherlands: Sufficiency of disclosure finally on the Dutch radar : Novozymes v. [read post]
16 Jun 2010, 3:02 pm
(Docket Report) US: Novozymes asserts Ethanol production enzyme patent against Danisco (Green Patent Blog) US: Use of terms like ‘monopoly’ and ‘milking’ prohibited at trial: Abbott Laboratories v. [read post]
27 May 2010, 3:20 am
Here is Think IP Strategy’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
24 May 2010, 10:49 pm
Ten Cate Offsetprodukten (EPLAW) District Court The Hague refers to ‘free-beer’ claims explaining disclosure insufficiently clear for skilled person to reach desired results: Novozymes v. [read post]